Sumatriptan Tablet
Product Images NDC 65862-147

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 65862-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

A line graph depicting the estimated probability of response over time in minutes from the initial dose for Sumatriptan Succinate tablets at doses of 25 mg, 50 mg, 100 mg, compared with placebo. The graph shows increasing response probabilities from 0 to 240 minutes post-dose for each treatment group.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)

A line graph showing the estimated probability of remission of pain over 24 hours from the initial dose for Sumatriptan Succinate tablets at strengths 25 mg, 50 mg, 100 mg, and placebo. The y-axis represents probability percentages, and the x-axis represents time in hours.*

FDA Label Image

Package Label-principal Display Panel (25 mg Blister Carton (9 Unit-dose))

Label for Sumatriptan Tablets, USP 25 mg, tablets by Aurobindo Pharma Limited. The label indicates 36 tablets per package, specifies each tablet contains 35 mg sumatriptan succinate USP equivalent to 25 mg sumatriptan, and includes dosing, storage, and distribution information. Made in India.*

FDA Label Image

Package Label-principal Display Panel (50 mg Blister Carton (9 Unit-dose))

Packaging label for Sumatriptan Tablets, USP 25 mg by Aurobindo Pharma Limited. The label indicates the product contains 9 unit-dose tablets with an NDC of 65862-146-36. It includes storage instructions, usage precautions, and distributor information. The label also features instructions with illustrations for removing tablets from the unit-dose packaging.*

FDA Label Image

Package Label-principal Display Panel (100 mg Blister Carton (9 Unit-dose))

Label for Sumatriptan Tablets USP 50 mg by Aurobindo Pharma Limited. The label states each tablet contains 70 mg sumatriptan succinate USP equivalent to 50 mg sumatriptan. The package contains 36 tablets. It includes storage instructions, dosage directions, and distributor information for Aurobindo Pharma USA, Inc., East Windsor, NJ. The label also features the NDC number 65862-147-59 and a barcode.*

FDA Label Image

Sumatriptan Fig6

Packaging label for Sumatriptan Tablets, USP 50 mg by Aurobindo Pharma Limited. The label indicates the product is prescription only and contains 9 unit-dose tablets. Each tablet has 70 mg sumatriptan succinate USP equivalent to 50 mg sumatriptan. The label includes dosage instructions, storage conditions, and visual instructions for tablet removal. NDC 65862-147-36 is visible.*

FDA Label Image

Sumatriptan Fig7

Label for Sumatriptan Tablets, USP 100 mg by Aurobindo Pharma Limited. The label indicates each tablet contains 140 mg sumatriptan succinate USP equivalent to 100 mg sumatriptan. The package contains 36 tablets. Distribution is by Aurobindo Pharma USA, Inc., with storage instructions and dosage note included. A barcode and NDC number 65862-148-59 are also visible.*

FDA Label Image

Sumatriptan Fig8

Packaging label for Sumatriptan Tablets, USP 100 mg by Aurobindo Pharma Limited. It includes 9 unit-dose tablets with instructions for use and storage. The label displays the NDC 65862-148-36 and specifies that each tablet contains 140 mg sumatriptan succinate USP equivalent to 100 mg sumatriptan. Distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical structure diagram of Sumatriptan Succinate showing molecular bonds and functional groups associated with the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.